PRECISE BIOMETRICS (PBCB.SG)
PRECISE BIOMETRICS (PBCB.SG) operates in Diversified Metals & Mining.
PRECISE BIOMETRICS (PBCB.SG) (PBCB) - Total Assets
Latest total assets as of September 2024: €200.87 Million EUR
Based on the latest financial reports, PRECISE BIOMETRICS (PBCB.SG) (PBCB) holds total assets worth €200.87 Million EUR as of September 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PRECISE BIOMETRICS (PBCB.SG) - Total Assets Trend (2016–2023)
This chart illustrates how PRECISE BIOMETRICS (PBCB.SG)’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PRECISE BIOMETRICS (PBCB.SG) - Asset Composition Analysis
Current Asset Composition (December 2023)
PRECISE BIOMETRICS (PBCB.SG)'s total assets of €200.87 Million consist of 34.6% current assets and 65.5% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 22.4% |
| Accounts Receivable | €13.58 Million | 6.4% |
| Inventory | €359.00K | 0.2% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €47.91 Million | 22.5% |
| Goodwill | €84.84 Million | 39.9% |
Asset Composition Trend (2016–2023)
This chart illustrates how PRECISE BIOMETRICS (PBCB.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PRECISE BIOMETRICS (PBCB.SG)'s current assets represent 34.6% of total assets in 2023, a decrease from 87.3% in 2016.
- Cash Position: Cash and equivalents constituted 22.4% of total assets in 2023, down from 69.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 61.0% of total assets, an increase from 5.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 39.9% of total assets.
PRECISE BIOMETRICS (PBCB.SG) Competitors by Total Assets
Key competitors of PRECISE BIOMETRICS (PBCB.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MANHATTAN ASSOC
BE:MHT
|
Germany | €698.14 Million |
|
TV BROADCAST
MU:TBCN
|
Germany | €6.25 Billion |
|
FIRST CITIZENS BC A
BE:FC6A
|
Germany | €220.57 Billion |
|
COSTCO WHSL
MU:CTO
|
Germany | €69.83 Billion |
|
GOLDMAN SACHS GROUP - Dusseldorf Stock Exchang
DU:GOS
|
Germany | €1.73 Trillion |
|
BURCKHARDT COMPRE N
MU:B5H
|
Germany | €1.07 Billion |
|
Public Service Company of New Mexico PFD 4.58%
PINK:PNMXO
|
USA | $886.19 Million |
|
2H0
F:2H0
|
Germany | €15.27 Million |
PRECISE BIOMETRICS (PBCB.SG) - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - PRECISE BIOMETRICS (PBCB.SG) generates 0.35x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - PRECISE BIOMETRICS (PBCB.SG) is currently not profitable relative to its asset base.
PRECISE BIOMETRICS (PBCB.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.36 | 2.36 | 3.40 |
| Quick Ratio | 2.35 | 2.34 | 3.40 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €37.30 Million | € 46.85 Million | € 76.54 Million |
PRECISE BIOMETRICS (PBCB.SG) - Advanced Valuation Insights
This section examines the relationship between PRECISE BIOMETRICS (PBCB.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -0.3% |
| Total Assets | €212.66 Million |
| Market Capitalization | $3.06K USD |
Valuation Analysis
Below Book Valuation: The market values PRECISE BIOMETRICS (PBCB.SG)'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: PRECISE BIOMETRICS (PBCB.SG)'s assets decreased by 0.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for PRECISE BIOMETRICS (PBCB.SG) (2016–2023)
The table below shows the annual total assets of PRECISE BIOMETRICS (PBCB.SG) from 2016 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | €212.66 Million | -0.26% |
| 2022-12-31 | €213.22 Million | -11.55% |
| 2021-12-31 | €241.05 Million | +57.60% |
| 2020-12-31 | €152.95 Million | -3.48% |
| 2019-12-31 | €158.47 Million | -0.20% |
| 2018-12-31 | €158.79 Million | -16.26% |
| 2017-12-31 | €189.62 Million | -3.30% |
| 2016-12-31 | €196.10 Million | -- |